Background: Atrial fibrillation (AF) symptoms are a major component of treatment decisions for patients with AF and impact quality of life and functional ability yet are poorly understood. Objective: This review aimed to determine what is known about the prevalence of symptoms and the association of symptoms to AF characteristics, psychological distress, sex, and race. Methods: We performed a structured review of AF symptoms as of March 2016 using PubMed, EMBASE, and CINAHL and reference searches of retrieved articles. Full-text, published, peer-reviewed, English-language articles were examined. Articles were included if they reported original research data on symptom prevalence and type among patients with AF. Results: The 3 most common symptoms were dyspnea, palpitations, and fatigue. The results suggested that, although AF characteristics are not a significant predictor of symptoms, tachycardia, female sex, race, and psychological distress have a positive association to symptoms. Conclusions: There is a scarcity of research examining symptoms in AF. Furthermore, the inconsistency in measurement methods and the failure to include diverse populations in AF research make it difficult to draw definitive conclusions from the current literature. Given the prevalence of AF in the United States and the impact of symptoms on quality of life and healthcare use, further research examining predictors of symptoms and interventions to alleviate symptoms is crucial.
trial fibrillation (AF) is the most common adult cardiac rhythm disorder. It is estimated that there are 5.2 million cases of AF in the United States, and this number is projected to increase to 12.1 million cases by 2030. 1 Conservative estimates suggest that healthcare expenditures due to AF-specific care in the United States cost $6 billion a year. 2 The main driver for seeking medical attention by persons with AF is the symptoms they experience.
3,4 Atrial fibrillation symptoms are associated with increased healthcare use, decreased quality of life (QOL), and poor health outcomes. 5Y11 Clinical decisions for procedural symptom management strategies, including cardioversions, ablations, and rhythm and rate control medications, are largely guided by patients" symptom reports.
12,13 The symptoms are highly variable. Between 25% and 30% of patients with AF are asymptomatic, whereas other patients report severe symptoms that affect their QOL. 4, 14 Among patients with symptomatic AF, a significant percentage has episodes that are asymptomatic, and the specific symptoms reported vary by type of AF. 15 The causal mechanism of AF symptoms and why symptoms are present in some patients and absent in others is unknown. 4, 16 There is limited understanding of the variability of symptoms with respect to psychosocial, racial, and sex-related differences. Women and nonwhites are significantly underrepresented in cardiovascular clinical trials. 17Y20 Because there are tremendous costs and potential complications related to AF treatment strategies, a thorough comprehension of symptoms caused by AF is essential. The purpose of this review is to improve understanding of what is known about the prevalence and type of symptoms in patients with AF and the association of AF symptoms to AF characteristics, psychological distress, sex, and race.
Methods
A structured literature search of the PubMed, CINAHL, and EMBASE databases was conducted with the assistance of a university librarian in March 2016 (Figure) . Search terms included the MeSH term ''atrial fibrillation.'' For symptom burden, the terms ''symptom burden,'' ''functional impairment,'' ''functional capacity,'' ''symptom,'' ''asymptomatic,'' and ''burden of symptoms'' were used. Functional impairment and functional capacity were included because they are often measured in studies of symptoms" effect on an individual. Reference lists were reviewed to identify relevant articles. No time limitations were imposed to ensure the inclusion of key seminal articles examining AF symptoms. This search of online databases yielded a total of 4085 articles. Twenty-six articles were removed after screening for duplicates. Abstracts and titles were reviewed for inclusion criteria. Articles that were potentially relevant were reviewed in full text. Where it was unclear whether a study should be included, the coauthor team was consulted. Eleven articles were identified by hand review. After screening, 38 articles remained and were reviewed using the following inclusion and exclusion criteria. The inclusion criteria were as follows: full text, published, peer reviewed, English language, 100% of participants given a diagnosis of AF, and data on symptom prevalence and type were collected and analyzed.
Data extracted from each article included prevalence and type of symptoms; the association between symptoms, sex, psychological distress, race, and AF characteristics; and instruments used. The extracted data are depicted in Tables 1 to 4 (Supplemental Digital Content 1, http://links.lww.com/JCN/A35). Quality assessments of each quantitative study were conducted using the Strengthening of the Reporting of Observational Studies in Epidemiology checklist. 21 The Strengthening of the Reporting of Observational Studies in Epidemiology checklist does not include a scoring system.
Our review is not intended to be all-inclusive or systematic. It represents the main studies examining psychological distress, sex, race, AF characteristics, and AF symptoms. This review is organized by discussing the prevalence and type of symptoms in AF and associations among AF characteristics, psychological distress, sex, race, and AF symptoms.
Results

Prevalence and Type of Symptoms
Fourteen studies that reported data on the prevalence and type of symptoms experienced by individuals with AF were examined (Table 1) . Atrial fibrillation symptom measurement instruments typically include palpitations, dyspnea, fatigue, chest pain, and dizziness. However, there is variance in the type and number of symptoms, time frame, and wording included in commonly used instruments (Table 2 ). In 3 prospective, cross-sectional studies that used the European Heart Rhythm Association symptom classification for AF, between 56% and 62% of patients had 1 or more AF symptoms in the past 7 days. 7,10,22 Whereas 1 study used a sample (n = 510) consisting only of patients with symptomatic AF, 22 the other 2 had larger samples (n = 9665 and 9542) that included asymptomatic and symptomatic patients and had comparable findings. 7, 10 Three studies similarly reported that 63% to 70% of study participants reported AF symptoms in the baseline data collection before tests of rhythm control interventions. 23Y25 Two of these studies did not describe the use of any instrument to measure AF symptoms, which may explain their findings of a slightly higher prevalence of current AF symptoms. 4, 23, 24 Dyspnea, fatigue, and palpitations were the 3 most commonly reported symptoms.
6,7,10,11,22,26Y29 Results from 1 qualitative study supported the reports of symptoms experienced in the quantitative studies. 30 Participants (n = 15) reported distress from abrupt occurrences of palpitations often accompanied by fatigue and shortness of breath, which they perceived as an AF episode. Most of the participants reported fatigue during AF episodes that lasted for a few days after the episode.
Association of Atrial Fibrillation Characteristics and Symptoms
Eleven studies examining the association of AF characteristics to symptoms were reviewed (Table 3) . Atrial fibrillation characteristics, including AF burden, heart rate when in AF, sinus rhythm rate, and frequency and severity of pauses, were measured through a pacemaker, a continuous looping monitor, or an electrocardiogram (EKG) recorder. Seven studies found essentially no association between the number and frequency of symptoms of AF reported by patients and AF characteristics measured by a continuous monitor. 27,28,31,43Y46 In contrast, 2 studies found a significantly greater AF burden in patients who reported symptoms in comparison with asymptomatic patients. 41, 42 In the study by Manganiello and colleagues, 42 continuous subcutaneous EKG monitoring was used to measure AF burden, and the sample (n = 113) consisted of participants at a single center who had undergone ablation for AF, which may explain the differing results.
Eight studies examining the association between heart rate and AF symptoms were reviewed. 11, 31, 34, 41, 42, 45, 48, 49 The findings of 7 studies support that there is a significant association of tachycardia to prevalence of symptomatic AF episodes (P G .001).
11, 34, 41, 42, 45, 48, 49 A heart rate greater than 100 beats per minute was associated with increased symptoms.
11, 42 One study did not find a significant association between heart rate and AF symptoms by measuring symptoms before applying a continuous monitor for 7 days to measure AF characteristics. 31 This data collection timing contrasts with the other studies described, where data were collected on the patients" reported symptoms in parallel with the monitoring period. Seven studies analyzed the sensitivity and positive predictive value of self-reported symptoms to detect the pacemaker"s report of an AF episode. The reported findings of 4 studies suggested a similar sensitivity of 19% or lower, 43Y46 with the exception of 2 studies that reported a sensitivity of 53% 47 and 91%. 41 However, the studies reported divergent positive predictive values of symptoms, ranging from values of a positive predictive value of 21% or lower 44, 46 to 63% and higher. 41, 43, 45, 47, 48 A weight reduction and cardiometabolic risk factor management intervention study found that AF symptoms, the number of episodes, and the cumulative duration of episodes were significantly reduced after the intervention, although whether the reduction in symptoms was correlated to the reduction in number of episodes and duration was not examined. 50 
Association of Psychological Distress and Atrial Fibrillation Symptoms
Seven studies examining the association of psychological distress to AF symptom burden were reviewed. 14,27,32,51Y54 The findings from 5 studies supported a significant (P G .05) association between depression and anxiety and AF symptoms. 27, 32, 51, 53, 54 The studies measured AF characteristics through EKGs, continuous looping monitors, and implanted cardioverter defibrillators and included these measurements in the analyses. Most of the studies used different measurements of psychological distress: the State Trait Anxiety Inventory, Profile of Mood States, participant report of psychological stress, Beck Depression Inventory, type D personality (DS14), and the Perceived Stress Scale-10, the Hospital Anxiety and Depression Scale A, and the Patient Health Questionnaire-9. Three of the studies adjusted for sex and age in the analysis, 1 study also adjusted for ethnicity, working status, education, smoking, and congestive heart failure, 53 and another study additionally adjusted for physical activity and body mass index. 32 A study that examined emotional response to symptoms found that 67% of participants (n = 150) reported that their symptoms worried them to some degree and 50% reported being frustrated by their symptoms. 55 A randomized controlled trial (n = 49) that examined the effects of yoga on AF measured both preanxiety and postanxiety and depression scores using the Zung self-assessment anxiety score 56 and Zung self-assessment depression score in addition to AF symptoms using a symptom diary and cardiac nonlooping event monitors and found that changes in anxiety and depression did not significantly correlate with changes in AF symptom experience, although the findings indicated a significant improvement in AF symptom burden, anxiety, and depression after the intervention. 52 Findings from 1 qualitative study supported the quantitative results in that most of the participants (n = 15) reported that emotional distress could precipitate an AF episode. 30 
Association of Sex and Atrial Fibrillation Symptoms
Most studies reported a significant, positive association between symptomatic AF and female sex (P G .05), 7,11,26,31,35,57,58 with the exception of 5 studies that found no association between symptomatic AF and sex (Table 4) . 27, 32, 42, 59, 60 The studies that found a significant association had larger sample sizes than the studies without findings indicative of a significant association. With the exception of one, 26 all of the studies that examined sex differences in symptoms were prospective cohort studies.
Association of Race and Atrial Fibrillation Symptoms
Notably, only three of the studies reviewed examined racial differences in symptom experience. 7, 22, 31 In each of these studies" samples, more than 85% of the participants were white. The studies found that nonwhites were significantly more likely to experience symptoms than whites (P G .05).
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Discussion
The findings indicate that there is limited research examining the associations between AF symptoms and AF characteristics, psychological distress, race, and sex. The lack of standardized assessment of AF symptoms, homogenous samples, and observational designs limits most previous research. 7 The research reviewed was mainly observational studies, and the findings were largely inconclusive. Few of the studies in this review were designed for the exclusive purpose of examining symptoms in AF. 49, 50, 52, 61 Many of the articles reported on symptoms through a subsample analysis where parts of the data and sample were taken from a larger study.
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One of the key methodological weaknesses of the previous research is the inconsistent measurement of AF symptoms. This variation in measurement complicates drawing conclusions from the literature because the studies used instruments with differing symptoms and periods. 10, 46, 53, 62 For example, the European Heart Rhythm Association includes a time frame of 1 week and 1 year to survey patients on symptoms, whereas the Atrial Tachyarrhythmia Symptom Severity Scale surveys about symptoms experienced in that past month. 63 Some instruments include as many as 16 symptoms, whereas others include 4. 37, 38 Differences in instruments display a lack of agreement among AF researchers over which symptoms can be attributed to AF and the appropriate period to understand patients" experiences with AF symptom burden. In addition, all commonly used instruments for the measurement of AF symptoms have limited reported evidence of reliability and validity for use among different races and ethnicity groups. 29, 38, 39, 64 Most of the instruments to measure symptoms were tested on predominantly white male samples, 29, 38, 39 making the applicability of the instruments to women and nonwhite populations questionable.
Atrial fibrillation symptoms are the primary reason patients seek medical treatment. 4 They are known to negatively affect QOL. 65, 66 Patients" report of symptoms is a major component of the treatment path for AF. 12 Yet, there is a universal inadequate understanding of AF symptoms. 4 The differences that exist among the AF symptom measurement instruments are both reflective of the lack of a thorough comprehension of AF symptom burden and an impediment to developing a deeper understanding of AF symptoms. There is a notable lack of qualitative studies, 30 which are necessary to understand the subjective and highly variable experience of AF symptom burden. Qualitative studies could also be used to better inform AF symptom measurement instruments, which currently vary in their measurements of the number, type, and time frame of symptoms, 38, 40, 64 and to enrich understanding of the different predictors of AF symptom burden. 30 In an examination of the existing literature on sex differences in AF symptoms, it is important to note that most of the sample was male in each study described in this review. Although estimates suggest that a man"s lifetime risk for AF at the age of 40 years is 26% whereas a woman"s lifetime risk is 23% at the age of 40 years, the difference is not large enough to account for the lack of female representation in the study samples. 67 Because the limited research investigating sex differences in symptom burden suggests that women may be more symptomatic than men, the prevalence of symptoms may not be generalizable to women because women were not equally represented in the samples. Findings from Rienstra and colleagues 24 suggest that asymptomatic patients have better outcomes; differences in symptoms may be contributing to disparate outcomes in marginalized populations. 68 Although the limited research examining race and AF symptoms suggests that nonwhites experience more symptoms, most research in AF is conducted on largely white samples. Efforts must be made to determine the potential causes that contribute to nonwhites being more symptomatic. The current findings reflect a need for improved symptom management for minorities.
It is difficult to draw conclusions based on the studies included in this review on the association of psychological distress and symptoms. Individuals with high levels of psychological distress before diagnosis of AF may be more likely to experience symptoms, psychological distress may precipitate a symptomatic AF episode, and the symptoms of AF may result in high levels of psychological distress.
14, 30, 53, 54 The randomized controlled trial examining the effects of yoga on AF symptoms found that changes in anxiety and depression did not significantly correlate with changes in AF symptom experience. Although a causal relationship cannot be determined from the studies in this review, the relationship may be bidirectional. However, future studies specifically designed to examine psychological distress and AF symptoms are needed to draw definitive conclusions.
There are limitations to the findings of this review. It is possible that informative articles were not found in the review because of the lack of consistency and broadly defined term ''symptoms.'' The review was not systematic, and it is possible that articles with valuable symptom data were not found. There were limited studies that were designed for the specific purpose of examining symptoms and the associated variables found in the literature. The results from this review remain valuable in highlighting knowledge gaps and methodological shortcomings that restrict the ability to draw evidence-based conclusions.
Research gaps exist in understanding the association between race and ethnicity, sex, psychological distress, and symptoms. The few studies that did include data on race and ethnicity reported a largely homogenous patient population. Findings suggest that psychological distress may be associated with symptoms. Improved understanding of the symptom experience of patients with AF and reliable, valid, and clinically feasible methods to measure symptom experience may lead to effective, tailored strategies to improve the quality and outcomes of AF care. 
